L. F. Zerilli

859 total citations
51 papers, 695 citations indexed

About

L. F. Zerilli is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, L. F. Zerilli has authored 51 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 15 papers in Organic Chemistry and 15 papers in Molecular Biology. Recurrent topics in L. F. Zerilli's work include Microbial Natural Products and Biosynthesis (14 papers), Mass Spectrometry Techniques and Applications (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). L. F. Zerilli is often cited by papers focused on Microbial Natural Products and Biosynthesis (14 papers), Mass Spectrometry Techniques and Applications (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). L. F. Zerilli collaborates with scholars based in Italy, Hungary and Mexico. L. F. Zerilli's co-authors include Károly Vékey, B. CAVALLERI, D. Edwards, Angelo Borghi, E. Martinelli, Pietro Ferrari, G.G. Gallo, Antonio Selva, Romeo Ciabatti and C. Coronelli and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Organic Chemistry and Journal of Chromatography A.

In The Last Decade

L. F. Zerilli

49 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. F. Zerilli Italy	16	261	236	202	142	89	51	695
M. Schach von Wittenau United States	17	191 0.7×	250 1.1×	207 1.0×	75 0.5×	38 0.4×	37	743
Kannan Rajamoorthi United States	7	99 0.4×	440 1.9×	155 0.8×	124 0.9×	43 0.5×	9	712
Xidong Feng United States	19	361 1.4×	466 2.0×	276 1.4×	205 1.4×	49 0.6×	30	1.1k
Makoto Sunagawa Japan	18	309 1.2×	280 1.2×	414 2.0×	62 0.4×	99 1.1×	70	952
Robert B. Morin United States	13	249 1.0×	284 1.2×	334 1.7×	81 0.6×	27 0.3×	34	718
Margherita Zanol Italy	14	102 0.4×	162 0.7×	64 0.3×	135 1.0×	51 0.6×	29	482
Harold E. Boaz United States	11	251 1.0×	401 1.7×	252 1.2×	82 0.6×	62 0.7×	26	1.1k
J. B. Taylor United Kingdom	15	377 1.4×	243 1.0×	150 0.7×	53 0.4×	31 0.3×	25	924
Thomas Lampe Germany	15	182 0.7×	477 2.0×	422 2.1×	36 0.3×	76 0.9×	22	1.2k
Gian Gualberto Gallo Italy	11	202 0.8×	191 0.8×	169 0.8×	43 0.3×	61 0.7×	22	447

Countries citing papers authored by L. F. Zerilli

Since Specialization

Citations

This map shows the geographic impact of L. F. Zerilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. F. Zerilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. F. Zerilli more than expected).

Fields of papers citing papers by L. F. Zerilli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. F. Zerilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. F. Zerilli. The network helps show where L. F. Zerilli may publish in the future.

Co-authorship network of co-authors of L. F. Zerilli

This figure shows the co-authorship network connecting the top 25 collaborators of L. F. Zerilli. A scholar is included among the top collaborators of L. F. Zerilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. F. Zerilli. L. F. Zerilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bossi, Alessandra, et al.. (1996). Purification of glycopeptide antibiotics by isoelectric focusing in multicompartment electrolyzers with Immobiline membranes. Electrophoresis. 17(7). 1234–1241. 19 indexed citations

Borghi, Angelo, et al.. (1996). Isolation and Structure Determination of a Novel Complex of the Teicoplanin Family.. The Journal of Antibiotics. 49(7). 644–650. 5 indexed citations

Gastaldo, Luciano, Romeo Ciabatti, L. F. Zerilli, et al.. (1992). Isolation, structure determination and biological activity of A-16686 factors A′ 1, A′ 2 and A′ 3 glycolipodepsipeptide antibiotics. Journal of Industrial Microbiology & Biotechnology. 11(1). 13–18. 7 indexed citations

Bernareggi, A., Angelo Borghi, Monica Borgonovi, et al.. (1992). Teicoplanin metabolism in humans. Antimicrobial Agents and Chemotherapy. 36(8). 1744–1749. 41 indexed citations

Zerilli, L. F., D. Edwards, Angelo Borghi, et al.. (1992). Determination of the acyl moieties of the antibiotic complex A40926 and their relation with the membrane lipids of the producer strain. Rapid Communications in Mass Spectrometry. 6(2). 109–114. 18 indexed citations

Borghi, Angelo, et al.. (1991). Microbial de-mannosylation and mannosylation of teicoplanin derivatives.. The Journal of Antibiotics. 44(12). 1444–1451. 14 indexed citations

Borghi, Angelo, D. Edwards, L. F. Zerilli, & Giancarlo Lancini. (1991). Factors affecting the normal and branched-chain acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus. Journal of General Microbiology. 137(3). 587–592. 35 indexed citations

Borghi, Angelo, et al.. (1989). Isolation and structure determination of two new analogs of teicoplanin, a glycopeptide antibiotic.. The Journal of Antibiotics. 42(3). 361–366. 25 indexed citations

Ciabatti, Romeo, et al.. (1989). Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation.. The Journal of Antibiotics. 42(2). 254–267. 76 indexed citations

10.

Vékey, Károly, D. Edwards, & L. F. Zerilli. (1989). Liquid chromatography-mass spectrometry coupling and its application in pharmaceutical research. Journal of Chromatography B Biomedical Sciences and Applications. 488(1). 73–85. 21 indexed citations

11.

CAVALLERI, B., et al.. (1989). Laser-induced vaporization mass spectrometry of rifamycins. Journal of Mass Spectrometry. 18(5). 301–307. 2 indexed citations

12.

Vékey, Károly, D. Edwards, & L. F. Zerilli. (1989). Liquid chromatographic—mass spectrometric studies on rifamycin antibiotics. Journal of Chromatography A. 474(1). 317–327. 20 indexed citations

13.

Zerilli, L. F., et al.. (1989). Teicoplanin metabolism in rats. Antimicrobial Agents and Chemotherapy. 33(10). 1791–1794. 2 indexed citations

14.

Bernareggi, A., et al.. (1987). Simultaneous determination of the two main metabolites of deflazacort in human plasma by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 5(2). 177–181. 10 indexed citations

15.

Assandri, Alessandro, et al.. (1985). Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dog. Xenobiotica. 15(12). 1089–1102. 3 indexed citations

16.

Ferrari, Pietro, et al.. (1985). Synthesis of N‐(2, 5‐[2‐¹³C]dimethyl‐1H‐pyrrol‐1‐YL)‐6‐(4‐morpholinyl)‐3‐Pyridazinamine hydrochloride. Journal of Labelled Compounds and Radiopharmaceuticals. 22(12). 1299–1307. 1 indexed citations

17.

Assandri, Alessandro, et al.. (1984). Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and man.. PubMed. 171. 9–23. 38 indexed citations

18.

Assandri, Alessandro, et al.. (1984). Metabolic fate of premazepam, a new anti-anxiety drug, in the rat and the dog.. Drug Metabolism and Disposition. 12(2). 257–263. 3 indexed citations

19.

Assandri, Alessandro, et al.. (1978). Metabolism of 5-isopropyl-1-methyl-2-nitro-1H-imidazole. Identification of some urinary metabolites in the dog.. Drug Metabolism and Disposition. 6(2). 109–113. 6 indexed citations

20.

Goldstein, Beth P., et al.. (1977). The Mechanism of Action of Nitro-heterocyclic Antimicrobial Drugs. Metabolic Activation by Micro-organisms. Journal of General Microbiology. 100(2). 283–298. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact